325 related articles for article (PubMed ID: 26781822)
1. Constitutional MLH1 methylation presenting with colonic polyposis syndrome and not Lynch syndrome.
Kidambi TD; Blanco A; Van Ziffle J; Terdiman JP
Fam Cancer; 2016 Apr; 15(2):275-80. PubMed ID: 26781822
[TBL] [Abstract][Full Text] [Related]
2. Contribution of MLH1 constitutional methylation for Lynch syndrome diagnosis in patients with tumor MLH1 downregulation.
Pinto D; Pinto C; Guerra J; Pinheiro M; Santos R; Vedeld HM; Yohannes Z; Peixoto A; Santos C; Pinto P; Lopes P; Lothe R; Lind GE; Henrique R; Teixeira MR
Cancer Med; 2018 Feb; 7(2):433-444. PubMed ID: 29341452
[TBL] [Abstract][Full Text] [Related]
3. MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria.
Crucianelli F; Tricarico R; Turchetti D; Gorelli G; Gensini F; Sestini R; Giunti L; Pedroni M; Ponz de Leon M; Civitelli S; Genuardi M
Epigenetics; 2014 Oct; 9(10):1431-8. PubMed ID: 25437057
[TBL] [Abstract][Full Text] [Related]
4. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
[TBL] [Abstract][Full Text] [Related]
5. Diversity of genetic events associated with MLH1 promoter methylation in Lynch syndrome families with heritable constitutional epimutation.
Leclerc J; Flament C; Lovecchio T; Delattre L; Ait Yahya E; Baert-Desurmont S; Burnichon N; Bronner M; Cabaret O; Lejeune S; Guimbaud R; Morin G; Mauillon J; Jonveaux P; Laurent-Puig P; Frébourg T; Porchet N; Buisine MP
Genet Med; 2018 Dec; 20(12):1589-1599. PubMed ID: 29790873
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of MLH1 constitutional epimutations as a cause of Lynch syndrome in unselected versus selected consecutive series of patients with colorectal cancer.
Castillejo A; Hernández-Illán E; Rodriguez-Soler M; Pérez-Carbonell L; Egoavil C; Barberá VM; Castillejo MI; Guarinos C; Martínez-de-Dueñas E; Juan MJ; Sánchez-Heras AB; García-Casado Z; Ruiz-Ponte C; Brea-Fernández A; Juárez M; Bujanda L; Clofent J; Llor X; Andreu M; Castells A; Carracedo A; Alenda C; Payá A; Jover R; Soto JL
J Med Genet; 2015 Jul; 52(7):498-502. PubMed ID: 25908759
[TBL] [Abstract][Full Text] [Related]
7. De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one.
Goel A; Nguyen TP; Leung HC; Nagasaka T; Rhees J; Hotchkiss E; Arnold M; Banerji P; Koi M; Kwok CT; Packham D; Lipton L; Boland CR; Ward RL; Hitchins MP
Int J Cancer; 2011 Feb; 128(4):869-78. PubMed ID: 20473912
[TBL] [Abstract][Full Text] [Related]
8. Finding the needle in a haystack: identification of cases of Lynch syndrome with MLH1 epimutation.
Hitchins MP
Fam Cancer; 2016 Jul; 15(3):413-22. PubMed ID: 26886015
[TBL] [Abstract][Full Text] [Related]
9. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
Carethers JM; Stoffel EM
World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
[TBL] [Abstract][Full Text] [Related]
10. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
Jin W; Wang LQ; Liu Y; Liu AJ
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
[No Abstract] [Full Text] [Related]
11. Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients.
Kato A; Sato N; Sugawara T; Takahashi K; Kito M; Makino K; Sato T; Shimizu D; Shirasawa H; Miura H; Sato W; Kumazawa Y; Sato A; Kumagai J; Terada Y
Am J Surg Pathol; 2016 Jun; 40(6):770-6. PubMed ID: 26848797
[TBL] [Abstract][Full Text] [Related]
12. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients.
Alemayehu A; Sebova K; Fridrichova I
Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713
[TBL] [Abstract][Full Text] [Related]
13. Identifying primary and secondary MLH1 epimutation carriers displaying low-level constitutional MLH1 methylation using droplet digital PCR and genome-wide DNA methylation profiling of colorectal cancers.
Joo JE; Mahmood K; Walker R; Georgeson P; Candiloro I; Clendenning M; Como J; Joseland S; Preston S; Graversen L; Wilding M; Field M; Lemon M; Wakeling J; Marfan H; Susman R; Isbister J; Edwards E; Bowman M; Kirk J; Ip E; McKay L; Antill Y; Hopper JL; Boussioutas A; Macrae FA; Dobrovic A; Jenkins MA; Rosty C; Winship IM; Buchanan DD
Clin Epigenetics; 2023 Jun; 15(1):95. PubMed ID: 37270516
[TBL] [Abstract][Full Text] [Related]
14. MLH1 promoter hypermethylation: are you absolutely sure about the absence of MLH1 germline mutation? About a new case.
Kientz C; Prieur F; Clemenson A; Joly MO; Stachowicz ML; Auclair J; Attignon V; Schiappa R; Wang Q
Fam Cancer; 2020 Jan; 19(1):11-14. PubMed ID: 31745674
[TBL] [Abstract][Full Text] [Related]
15. Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.
Yokoyama T; Takehara K; Sugimoto N; Kaneko K; Fujimoto E; Okazawa-Sakai M; Okame S; Shiroyama Y; Yokoyama T; Teramoto N; Ohsumi S; Saito S; Imai K; Sugano K
BMC Cancer; 2018 May; 18(1):576. PubMed ID: 29783979
[TBL] [Abstract][Full Text] [Related]
16. Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome.
Morak M; Koehler U; Schackert HK; Steinke V; Royer-Pokora B; Schulmann K; Kloor M; Höchter W; Weingart J; Keiling C; Massdorf T; Holinski-Feder E;
J Med Genet; 2011 Aug; 48(8):513-9. PubMed ID: 21712435
[TBL] [Abstract][Full Text] [Related]
17. Evidence of constitutional MLH1 epimutation associated to transgenerational inheritance of cancer susceptibility.
Crépin M; Dieu MC; Lejeune S; Escande F; Boidin D; Porchet N; Morin G; Manouvrier S; Mathieu M; Buisine MP
Hum Mutat; 2012 Jan; 33(1):180-8. PubMed ID: 21953887
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical staining for p16 and BRAFV600E is useful to distinguish between sporadic and hereditary (Lynch syndrome-related) microsatellite instable colorectal carcinomas.
Boissière-Michot F; Frugier H; Ho-Pun-Cheung A; Lopez-Crapez E; Duffour J; Bibeau F
Virchows Arch; 2016 Aug; 469(2):135-44. PubMed ID: 27220764
[TBL] [Abstract][Full Text] [Related]
19. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
[TBL] [Abstract][Full Text] [Related]
20. Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing.
Alqahtani M; Edwards C; Buzzacott N; Carpenter K; Alsaleh K; Alsheikh A; Abozeed W; Mashhour M; Almousa A; Housawi Y; Al Hawwaj S; Iacopetta B
Fam Cancer; 2018 Apr; 17(2):197-203. PubMed ID: 28643016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
